Ibm Retirement Fund Exelixis, Inc. Transaction History

Ibm Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 12, 2021	SELL	$17.95 - $25.56 $188,762 - $268,788	-10,516 Closed	0 $0
Q1 2021 Apr 22, 2021	SELL	$20.53 - $25.22 $17,060 - $20,957	-831 Reduced 7.32%	10,516 $238,000
Q4 2020 Jan 25, 2021	SELL	$18.39 - $24.8 $16,606 - $22,394	-903 Reduced 7.37%	11,347 $228,000
Q3 2020 Oct 16, 2020	BUY	$20.67 - $26.94 $57,359 - $74,758	2,775 Added 29.29%	12,250 $300,000
Q2 2020 Jul 08, 2020	BUY	$16.46 - $27.42 $155,958 - $259,804	9,475 New	9,475 $225,000

467

239M

2.04M

1.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Ibm Retirement Fund with notifications on news.